Prosaic 发表于 2025-3-25 06:41:43

http://reply.papertrans.cn/2/158/15793/15793-21.png

Asseverate 发表于 2025-3-25 09:41:31

http://reply.papertrans.cn/2/158/15793/15793-22.png

obeisance 发表于 2025-3-25 12:09:56

Submitted on: 18 July 2018.
Revised on: 29 September 2018.
Accepted on: 16 October 2018.

___________________JOURNAL OF CHEMOTHERAPY---TAYLOR & FRANCIS LTD

评论者 发表于 2025-3-25 16:26:50

Submitted on: 17 June 2021.
Revised on: 17 July 2021.
Accepted on: 31 August 2021.

___________________JOURNAL OF CHEMOTHERAPY---TAYLOR & FRANCIS LTD

Indelible 发表于 2025-3-25 23:32:06

http://reply.papertrans.cn/2/158/15793/15793-25.png

遭受 发表于 2025-3-26 02:42:26

Submitted on: 19 October 2022.
Revised on: 08 December 2022.
Accepted on: 30 January 2023.

___________________JOURNAL OF CHEMOTHERAPY---TAYLOR & FRANCIS LTD

征税 发表于 2025-3-26 07:28:59

Submitted on: 26 March 2003.
Revised on: 04 June 2003.
Accepted on: 01 July 2003.

___________________JOURNAL OF CHEMOTHERAPY---TAYLOR & FRANCIS LTD

Carcinoma 发表于 2025-3-26 12:11:21

http://reply.papertrans.cn/2/158/15793/15793-28.png

Lament 发表于 2025-3-26 15:08:14

Submitted on: 11 April 2009.
Revised on: 02 May 2009.
Accepted on: 13 May 2009.

___________________JOURNAL OF CHEMOTHERAPY---TAYLOR & FRANCIS LTD

lattice 发表于 2025-3-26 19:11:38

Submitted on: 06 January 2014.
Revised on: 11 March 2014.
Accepted on: 13 April 2014.

___________________JOURNAL OF CHEMOTHERAPY---TAYLOR & FRANCIS LTD
页: 1 2 [3] 4
查看完整版本: SCIE期刊JOURNAL OF CHEMOTHERAPY 2024/2025影响因子:1.981 (J CHEMOTHERAPY) (1120-009X). (PHARMACOLOGY & PHARMACY)(药理学与药学)Scienc